Therapeutic Solutions International Inc (TSOI)

[BigBadWolf]

10Q https://fintel.io/doc/sec-therapeutic-solutions-international-inc-1419051-10q-2023-november-14-19675-1480

As of November 14, 2023, 3,736,449,424 shares of the registrant’s common stock, par value of $0.001 per shares, were outstanding.

No increase 17 days

Outstanding Shares 3,736,449,424 10/27/2023

The following factors are among those that may cause actual results to differ materially from our forward-looking statements:

? Need for additional capital;

? Limited operating history in our new business model;

? Limited experience introducing new products;

? Our ability to successfully expand our operations and manage our future growth;

? Difficulty in managing our growth and expansion;

? Dilutive effects of any raising of additional capital;

? The deterioration of global economic conditions and the decline of consumer confidence and spending;

? Material weaknesses reported in our internal control over financial reporting;

? Our ability to protect intellectual property rights and the value of our products;

? The potential for product liability claims against us;

? Our dependence on third party manufacturers to manufacture our products;

? Our common stock is currently classified as a penny stock;

? Our stock price may experience future volatility;

? The illiquidity of our common stock; and

? Substantial sales of shares of our common stock.

? Other factors not specifically described above, including the other risks, uncertainties, and contingencies described under “Description of Business”, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Items 1 and 7 of our Annual Report on Form 10-K for the year ended December 31, 2022.

When considering these forward-looking statements, you should keep in mind the cautionary statements in this report and the documents incorporated by reference. We have no obligation and do not undertake to update or revise any such forward-looking statements to reflect events or circumstances after the date of this report.

Actual results may vary materially from those in such forward-looking statements as a result of various factors. No assurance can be given that the risk factors described in this Quarterly Report on Form 10-Q are all of the factors that could cause actual results to vary materially from the forward-looking statements. References in this Quarterly Report on Form 10-Q to the “Company,” “TSOI,” “we,” “our,” and “us” refer to Therapeutic Solutions International, Inc.